These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 30205580

  • 1. The Effects of Berberine on the Gut Microbiota in Apc min/+ Mice Fed with a High Fat Diet.
    Wang H, Guan L, Li J, Lai M, Wen X.
    Molecules; 2018 Sep 08; 23(9):. PubMed ID: 30205580
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
    Shi Y, Hu J, Geng J, Hu T, Wang B, Yan W, Jiang Y, Li J, Liu S.
    Biomed Pharmacother; 2018 Nov 08; 107():1556-1563. PubMed ID: 30257374
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Berberine alters gut microbial function through modulation of bile acids.
    Wolf PG, Devendran S, Doden HL, Ly LK, Moore T, Takei H, Nittono H, Murai T, Kurosawa T, Chlipala GE, Green SJ, Kakiyama G, Kashyap P, McCracken VJ, Gaskins HR, Gillevet PM, Ridlon JM.
    BMC Microbiol; 2021 Jan 11; 21(1):24. PubMed ID: 33430766
    [Abstract] [Full Text] [Related]

  • 9. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
    Yue SJ, Liu J, Wang AT, Meng XT, Yang ZR, Peng C, Guan HS, Wang CY, Yan D.
    Am J Physiol Endocrinol Metab; 2019 Jan 01; 316(1):E73-E85. PubMed ID: 30422704
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
    Zhao R, Coker OO, Wu J, Zhou Y, Zhao L, Nakatsu G, Bian X, Wei H, Chan AWH, Sung JJY, Chan FKL, El-Omar E, Yu J.
    Gastroenterology; 2020 Sep 01; 159(3):969-983.e4. PubMed ID: 32387495
    [Abstract] [Full Text] [Related]

  • 12. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R, Yang N, Kong B, Cao B, Feng D, Yu X, Ge C, Huang J, Shen J, Wang P, Feng S, Fei F, Guo J, He J, Aa N, Chen Q, Pan Y, Schumacher JD, Yang CS, Guo GL, Aa J, Wang G.
    Mol Pharmacol; 2017 Feb 01; 91(2):110-122. PubMed ID: 27932556
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
    Yao Y, Chen H, Yan L, Wang W, Wang D.
    Biomed Pharmacother; 2020 Nov 01; 131():110669. PubMed ID: 32937246
    [Abstract] [Full Text] [Related]

  • 15. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
    Sun T, Liu S, Zhou Y, Yao Z, Zhang D, Cao S, Wei Z, Tan B, Li Y, Lian Z, Wang S.
    Oncotarget; 2017 Jan 03; 8(1):444-457. PubMed ID: 27880935
    [Abstract] [Full Text] [Related]

  • 16. Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.
    Wang Y, Tong Q, Shou JW, Zhao ZX, Li XY, Zhang XF, Ma SR, He CY, Lin Y, Wen BY, Guo F, Fu J, Jiang JD.
    Theranostics; 2017 Jan 03; 7(9):2443-2451. PubMed ID: 28744326
    [Abstract] [Full Text] [Related]

  • 17. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression.
    Yang YN, Wang QC, Xu W, Yu J, Zhang H, Wu C.
    Biomed Pharmacother; 2022 Nov 03; 155():113749. PubMed ID: 36174380
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites.
    Yang J, Wei H, Zhou Y, Szeto CH, Li C, Lin Y, Coker OO, Lau HCH, Chan AWH, Sung JJY, Yu J.
    Gastroenterology; 2022 Jan 03; 162(1):135-149.e2. PubMed ID: 34461052
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.